CIK 0001831828 · Large accelerated filer
Vera Therapeutics, Inc.
Sign in to watch- Ticker
- VERA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812744449
- Phone
- 650-770-0077
- Business address
- 2000 SIERRA POINT PARKWAY, SUITE 1200, BRISBANE, CA, 94005
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,334,142
- in 2 filings, $1.3M under 10b5-1 plans
Net −$1,334,142. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 98 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-11-13 | Fordyce Marshall PRESIDENT AND CEO | Option exercise 10b5-1 | +3,307 | $2.90 | $10K | 89,249 |
| 2024-11-13 | Fordyce Marshall PRESIDENT AND CEO | Sale 10b5-1 | −3,307 | $50.28 | $166K | 85,942 |
| 2024-11-13 | Fordyce Marshall PRESIDENT AND CEO | Option exercise 10b5-1 | +100 | $2.90 | $290 | 86,042 |
| 2024-11-13 | Fordyce Marshall PRESIDENT AND CEO | Sale 10b5-1 | −100 | $51.20 | $5K | 85,942 |
| 2024-11-13 | Fordyce Marshall PRESIDENT AND CEO | Option exercise 10b5-1 | +1,565 | $2.90 | $5K | 87,507 |
| 2024-11-13 | Fordyce Marshall PRESIDENT AND CEO | Sale 10b5-1 | −1,565 | $49.59 | $78K | 85,942 |
| 2024-11-13 | Fordyce Marshall PRESIDENT AND CEO | Option exercise 10b5-1 | +310 | $2.90 | $898 | 86,252 |
| 2024-11-13 | Fordyce Marshall PRESIDENT AND CEO | Sale 10b5-1 | −310 | $50.35 | $16K | 85,942 |
| 2024-11-13 | Fordyce Marshall PRESIDENT AND CEO | Option exercise 10b5-1 | +1,875 | $2.90 | $5K | 87,817 |
| 2024-11-13 | Fordyce Marshall PRESIDENT AND CEO | Sale 10b5-1 | −1,875 | $49.57 | $93K | 85,942 |
| 2024-11-13 | Fordyce Marshall PRESIDENT AND CEO | Option exercise 10b5-1 | +1,875 | $2.90 | $5K | 87,817 |
| 2024-11-13 | Fordyce Marshall PRESIDENT AND CEO | Sale 10b5-1 | −1,875 | $49.52 | $93K | 85,942 |
| 2024-11-13 | Fordyce Marshall PRESIDENT AND CEO | Option exercise 10b5-1 | +1,875 | $2.90 | $5K | 87,817 |
| 2024-11-13 | Fordyce Marshall PRESIDENT AND CEO | Sale 10b5-1 | −1,875 | $49.50 | $93K | 85,942 |
| 2024-11-13 | Fordyce Marshall PRESIDENT AND CEO | Option exercise 10b5-1 | +7,500 | $2.90 | $22K | 93,442 |
| 2024-11-13 | Fordyce Marshall PRESIDENT AND CEO | Sale 10b5-1 | −7,500 | $49.00 | $368K | 85,942 |
| 2024-11-13 | Fordyce Marshall PRESIDENT AND CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −15,625 | 753,587 | ||
| 2024-11-13 | Fordyce Marshall PRESIDENT AND CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,875 | 751,712 | ||
| 2024-11-13 | Fordyce Marshall PRESIDENT AND CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,875 | 749,837 | ||
| 2024-11-13 | Fordyce Marshall PRESIDENT AND CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,875 | 747,962 |
Page 9 of 17 · 321 trades